Layn Natural Ingredients recently inaugurated an expanded biotechnology facility, which will significantly enhance the company's capabilities in precision fermentation and enzyme production. The first innovation to emerge from the facility is Galacan, a next-gen beta glucan.
Spiral Heteropolysaccharide for Improved Bioavailability
Galacan is described as a highly bioavailable water-soluble heteropolysaccharide, developed as a powerful alternative to traditional beta glucans. According to the company, unlike beta glucans derived from oats, yeast, algae or mushrooms, Galacan is created via precision fermentation, forming a unique spiral-shaped heteropolysaccharide.
This structure is said to enhance receptor interaction on immune cells, improving both bioavailability and efficacy. According to the company, the ingredient marks a major advancement in the field of immune and metabolic health.
Water Soluble and Versatile Across Categories
Galacan also demonstrates excellent water solubility, per the company, making it highly versatile for various formulations. Applications include dietary supplements, functional foods, beverages and personal care.
Galacan offers key benefits for:
- Skin health and healing: With INCI certification, Galacan supports wound healing and tissue regeneration, reportedly ideal for nutricosmetic and topical applications.
- Gut health, promoting beneficial bacteria like Lactobacillus brevis and supporting gut lining integrity.
- Healthy inflammation response, helping modulate pro-inflammatory cytokines to support metabolic wellness.
- Blood sugar support, enhancing pancreatic beta-cell function and promoting healthy glucose levels.
- Stamina and energy, boosting ATP production, aiding in fatigue reduction and sustained energy.
Regulatory and Market Readiness
Galacan has achieved self-affirmed GRAS status and is undergoing FDA GRAS and Novel Food evaluations. Per the company, this will pave the way for its use in a wide array of consumer health products.
In addition, through its precision fermentation and enzyme technologies, Layn is ensuring sustainability and non-GMO compliance across its product portfolio.
“The expansion of our biotechnology facility marks a pivotal step for Layn, enabling us to set new standards in natural ingredient development,” said James Roza, chief scientific officer at Layn Natural Ingredients.
